skip to main content

COVID-19 Information and Guidance

Third Annual Multi-Stakeholder Texas Collaborative Center for Hepatocellular Cancer (TECH) Symposium

The Texas Collaborative Center for Hepatocellular Cancer (TeCH) at Baylor College of Medicine will host its third annual symposium on September 17, 2022, under the leadership of Dr. Hashem El-Serag. The event will feature several local and national speakers as well as a keynote address by Dr. John Ward, director of the Task Force for Global Health’s Coalition for Global Hepatitis Elimination.

The goal of the symposium is to discuss and chart a path on how to move from science to policy and programs to eliminate hepatocellular carcinoma (HCC), the most common type of primary liver cancer.

With one of the highest rates of end-stage liver disease and liver cancer in the country, Texas is uniquely impacted by this highly lethal disease.

The symposium will combine presentations on the gaps and opportunities for preventing HCC in Texas with a multi-stakeholder conference that will bring together elected officials and decision-makers, community groups, leaders of health care organizations, professional societies, and insurance and industry representatives. Stakeholders across the care continuum will consider how to best bridge the gaps in prevention and treatment of HCC in Texas, with a focus on driving advocacy efforts for policies aimed at statewide elimination of liver cancer/HCC and its underlying risk factors: hepatitis C and B, alcoholic liver disease and fatty liver disease. 

This event is co-sponsored by the Baker Institute Center for Health and Biosciences and the Texas Collaborative Center for Hepatocellular Cancer (TeCH) at Baylor College of Medicine (funded by the Cancer Prevention and Research Institute of Texas).

Follow @BakerCHB on Twitter, and join the conversation online with #BakerHealth.


This is a private event open and free to special guests through the link in their email invitation. Please register using the emailed link, or contact Ariel Harrison at Guests may attend either in person or virtually via Zoom.

Events and webinars are powered by the contributions of our donors and members. Please consider supporting our work by making a gift or joining a membership group. Learn more here or text BAKER to 243725 to give today.


8:00 a.m.



Session I: Overview of the Liver Cancer Epidemic

Welcome and Overview of the Task Ahead

Hashem B. El-Serag, M.D., MPH
Chair and Professor, Department of Medicine, Baylor College of Medicine, Houston

Liver Cancer 101: Disease Burden, Risk Factors and Disparities

Aaron P. Thrift, Ph.D.
Associate Professor and Epidemiologoist, Department of Medicine, Baylor College of Medicine, Houston

8:40 a.m.



Session II: Advances in Risk Assessment and Prevention

Current State of and Gaps in Liver Cancer Prevention

Sumeet K. Asrani, M.D., MSc
Professor of Medicine and Transplant Hepatologist, Baylor University Medical Center, Baylor Scott & White Health, Dallas

Addressing Gaps 1: Risk Assessment as a Tool in Prevention of Liver Cancer

Brett Fortune, M.D., MSc
, Montefiore Health System and Albert Einstein College of Medicine, New York

Addressing Gaps 2: Prevention of Liver Cancer in the Community and Primary Care settings

Barbara Turner, M.D., MSEd, MA, MACP
Clinical Professor of Medicine, Gehr Family Center for Health Systems Science and Innovation, University of Southern California, Los Angeles

9:40 a.m.




10:00 a.m.



Coffee Break  

10:20 a.m


Session III: Advances in Detection, Diagnosis and Treatment of Liver Cancer

Current State of and Gaps in Detection and Diagnosis of Liver Cancer

Amit Singal, M.D.
Professor of Medicine and Medical Director, Liver Tumor Program and Clinical Chief of Hepatology, UT Southwestern Medical Center, Dallas

Current Landscape of Treatment for Liver Cancer

Ahmed O. Kaseb, M.D.
Professor, Department of Gastrointestinal (GI) Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston

Addressing Gaps 3: Detection, Diagnosis and Treatment of Liver Cancer at the Community Level

Nicole Rich, M.D., MSc
Assistant Professor of Internal Medicine, UT Southwestern Medical Center, Dallas

11:20 a.m.    


11:40 a.m.    

Keynote Address and Lunch

From Science to Policy: Hepatitis C Elimination

John Ward, M.D.
Director, Coalition for Global Hepatitis Elimination, Task Force for Global Health, Atlanta

12:20 p.m.    

Session IV: Implementing Change

Toward Policy Change — Payer Perspective

Salil Deshpande, M.D., MBA
Chief Medical Officer, UnitedHealthcare Community Plan

Putting it all together: What does an ideal road map look like?

Fasiha Kanwal, M.D., MSHS
Professor of Medicine and Chief Section of Gastroenterology and Hepatology, Baylor College of Medicine, Houston

1:00 p.m.    

Multi-stakeholder Conference

2:30 p.m.    



Sat, Sept. 17, 2022
8 a.m. - 3 p.m.
(GMT-0500) US/Central


James A. Baker III Hall, Rice University
Rice University's Baker Institute — 6100 Main Street
Houston, Texas 77005

Doré Commons